| Literature DB >> 21414667 |
J L V Shaw1, P Fitch, J Cartwright, G Entrican, J Schwarze, H O D Critchley, A W Horne.
Abstract
Lymphoid and myeloid cell populations in human endometrium are well-documented and are known to play important roles in providing immune tolerance, controlling trophoblast invasion, and mediating vascular remodeling. Immune cell populations in the Fallopian tube have not been comprehensively studied. The aim of this study was to characterize lymphoid and myeloid cell populations in non-pregnant Fallopian tube and determine whether they are altered in Fallopian tube from women with ectopic pregnancy. Fallopian tube was analyzed by flow cytometry and immunohistochemistry. Populations of CD3+ (CD4+ and CD8+) lymphocytes, LIN1-HLADR+ (CD123+ and CD11c+) dendritic cells, monocytes, neutrophils, and CD56(dim)CD16- natural killer (NK) cells were demonstrated to be present in non-pregnant Fallopian tube. CD123+ dendritic cells were predominant over CD11c+ dendritic cells. Numbers of CD11c+ cells were significantly higher in the progesterone-dominant mid-luteal phase of the menstrual cycle compared with the follicular phase. Numbers of CD45+ leukocytes, CD68+ cells, and CD11c+ cells were higher in Fallopian tube from women with ectopic pregnancy compared with mid-luteal phase Fallopian tube. These data will advance our understanding of normal human Fallopian tube physiology and disorders of Fallopian tube function, such as ectopic pregnancy. CrownEntities:
Mesh:
Substances:
Year: 2011 PMID: 21414667 PMCID: PMC3092852 DOI: 10.1016/j.jri.2011.01.014
Source DB: PubMed Journal: J Reprod Immunol ISSN: 0165-0378 Impact factor: 4.054
Fig. 1Analysis of lymphocyte and dendritic cell populations in human Fallopian tube by flow cytometry. Fallopian tube biopsies (n = 5) were minced and digested to form a single cell suspension. Cells were stained with antibodies in combination to analyze specific populations of cells. (a) Cells positive for staining with APC-conjugated CD3 were gated and are shown as either CD4+ (Q1) or CD8+ (Q4) T cells. (b) Percentages of CD3+CD4+ and CD3+CD8+ T cells. (c) Cells positively staining for HLADR-PERCP. (d) Cells positively staining with a combination lineage marker 1 (LIN1)-FITC. (e) Cells positively stained for HLADR and not stained with LIN1 are shown in P10. (f) HLADR+LIN1− cells were gated and populations of HLADR+LIN1−CD123+ and HLADR+LIN1−CD11c+ subpopulations are shown in P3 and P4 respectively. (g) Isotype control for CD123 antibody. (h) Percentages of LIN1−HLADR+ cells that were CD123+ or CD11c+. P2 represents cells that were HLADR+LIN1−, but negative for CD11c or CD123. These cells likely include epithelial cells.
Fig. 2Analysis of monocyte and NK cell populations in human Fallopian tube by flow cytometry. Fallopian tube biopsies (n = 5) were minced and digested to form a single cell suspension. Cells were stained with antibodies in combination to analyze specific populations of cells. (a) Populations of live cells staining with CD16 (P2) or CD14 (P3). (b) Isotype control for CD16 and CD14 antibodies. (c) Cells positively stained for CD16 were gated and are shown in the plot as forward scatter versus side-scatter to demonstrate the degree of granularity of these cells. (d) The population of CD3−CD56dim cells are shown in Q4. (e) Isotype control for CD56 antibody. (f) Plot shows that the population of CD56dim cells are CD16−. (g) Isotype control for CD56 shown with CD16.
Fig. 3Immunohistochemical localization of CD45+, CD68+, and CD11c+ cells in human Fallopian tube. (a) CD45+ leukocytes, (b) CD68+, and (c) CD11c+ cells localized to the epithelium of human Fallopian tube taken from the mid-luteal phase of the menstrual cycle.
Fig. 4Quantification of CD45+, CD68+, and CD11c+ cells in Fallopian tube from women across the menstrual cycle and from women with ectopic pregnancy. Cells stained positively for CD45 (a), CD68 (b) or CD11c (c) by immunohistochemistry were quantified using stereology software.
Clinical information for Fallopian tube samples across the menstrual cycle.
| Sample | Cycle phase | Serum estrogen (pmol/L) | Serum progesterone (nmol/L) | Reason for surgery |
|---|---|---|---|---|
| 1 | Follicular | 1023 | 0.8 | HMB |
| 2 | Follicular | 940 | 3.8 | HMB, PP |
| 3 | Follicular | 829 | 4.2 | HMB, PP |
| 4 | Follicular | 771 | 5.2 | HMB |
| 5 | Follicular | 116 | 2.9 | HMB, PP |
| 6 | Follicular | 55 | 2.2 | HMB, PP |
| 7 | Mid-luteal | 550 | 88.0 | Dysmen |
| 8 | Mid-luteal | 242 | 53.1 | HMB, dysmen |
| 9 | Mid-luteal | 201 | 24.6 | HMB, PP |
| 10 | Mid-luteal | 400 | 80.5 | HMB, dysmen |
| 11 | Mid-luteal | 1633 | 54.4 | HMB, dysmen |
| 12 | Mid-luteal | 424 | 76.9 | PP |
| 13 | Mid-luteal | 243 | 38.1 | HMB |
HMB = heavy menstrual bleeding; PP = pelvic pain; dysmen = dysmenorrhea.
Clinical information for Fallopian tubes from ectopic pregnancy.
| Sample | hCG (IU/L) | Serum progesterone (nmol/L) | Gestational age (days) |
|---|---|---|---|
| 1 | 5981 | 158.1 | 41 |
| 2 | 453 | 8.8 | 47 |
| 3 | 10,285 | 31.7 | 46 |
| 4 | 1082 | 23.9 | 52 |
| 5 | 508 | 7.1 | 44 |